Phase I Clinical Study to Evaluate the Safety and Efficacy of SSGJ-706 Monotherapy for Patients With Advanced Solid Tumors

NCT06533605 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors Patients

Interventions

DRUG: SSGJ-706

Sponsor

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.